What's the incidence, risk factors, & outcomes of atrial #MR? 👀 out our Article examining these❓️. Proud to see this out and 🙏 to mentors & #EHJCVI @SorinVPislaru @michelenahector Dr.Patricia Pellikka Grace Lin, MD, MBA Denisa Muraru Mayo Clinic Rochester Cardiology Fellows @GeraldMaurer academic.oup.com/ehjcimaging/ad…

✨OPEN HOUSE ALERT✨ Join us Tuesday, August 29th to learn more about Mayo Clinic Internal Medicine Residency in Rochester, MN! Details below. We can’t wait to connect with you & share why we❤️our program! Carrie Thompson, MD Benjamin Stultz, MD Alessandra Tomasi Chris Heinrich M.D.

Next time you see a patient with at least moderate TR, make sure to try the TRIO calculator 📱 Here is the QR code to TRIO

Left atrial appendage closure (LAAC) is a procedure aimed at reducing stroke risk in atrial fibrillation. Our recently published systematic review identified risk factors and management approaches for peri-device leaks after LAAC. Mohamad Alabdaljabar link.springer.com/article/10.100…

Mayo Clinic Internal Medicine Residency Rochester crew at ACC! Mayo Clinic CV

Despite that HCM female patients were older with higher baseline pressures than male patients, they had better survival after ASA. Very grateful to my mentor Mack Eleid, our team, and my residency program Mayo Clinic Internal Medicine Residency Rochester for their generous support!✨

Excited to be at #ASE24 in Portland⛅️ to talk about the forgotten, and one of my favorite valves, tricuspid valve (TV 📺)! Please join me today to know more about the impact of TR etiology on outcomes📉📈

Many exciting events at #ASE24, so I got you if you can’t make it today. June 16th will be the second date to remember. Primary vs Secondary vs Lead-associated TR, who does better? Do these groups have distinct risk profiles? Can we use TRIO? 🧐

80% of #ASE24 attendees are about to know: What is TRIO?📺 -Simple prognostic tool to estimate mortality based on clinical parameters Does it work?📈 -Our study with >13k pts shows it does! PMID: 35933133 Have I used it?🤔 -I have! Very helpful in discussing TR severity with pts

📌Cardiac cysts are rare 📌Consensus on management of cardiac cysts is not established. If symptoms or concern for malignancy/infection, treatment may include surgery 📌 TTE with contrast helps in delineating the nature of cysts (infection/malignancy) #ASE24

Not only do living souls migrate! An interesting case of an iliac vein stent journey to the RV. The patient presented with SoB and chest pain 🛑 I wish I know how the patient was managed 🧐, but I guess we will figure this out next Sunday 🗓️ #ASE24

Which coronary plaques are the trouble makers? 💡Those with high risk features (HRP) and with an FFR <80% #ASE24 American Society of Echocardiography

Healthy adults presenting with cardiac symptoms and severe biV failure: - exposure (infections, activities/sports, substance use) - family history - workup (blood, echo, imaging, cath, and biopsy may be needed) Despite all of this, the diagnosis can be challenging #ASE2024

The love of tricuspid valve doesn’t know age! Dr. O’Meara presenting about progression/impact of fetal non-Ebstenoid TR. 📌 Severe TR likely to stay severe 📌 Fetuses with severe are more likely to need CICU #ASE2024

A great post from one of the helpful nice people. I hope this help. Please add to these hospitals Montefiore hospital nyc and university of Florida. Visit the website of each hospital to approach them. #MedTwittet #IMGs #match2025